RSS-Feed abonnieren

DOI: 10.1055/s-0045-1811949
Impact of Ramadan Fasting in People with Type 1 Diabetes and Diabetic Kidney Disease: Insights from the DaR Global Survey
Authors
Funding and Sponsorship None.

Abstract
Background
Despite the scarcity of data, individuals with type 1 diabetes mellitus (T1D) and diabetic kidney disease (DKD) are considered at moderate to high risk for Ramadan fasting and are individually advised against fasting.
Objectives
This subgroup analysis of the Diabetes and Ramadan (DaR) global survey was conducted to evaluate the outcomes and characteristics of patients with T1D complicated by DKD who observe fasting and to compare their outcomes with those of fasting people living with T1D uncomplicated by DKD.
Methods
Using a specifically designed SurveyMonkey questionnaire, Muslim individuals with T1D and DKD were surveyed in several countries from different geographical regions and compared statistically to people with T1D without DKD or associated comorbidities.
Results
Note that 53.8% (N = 86) of individuals with T1D and DKD fasted during Ramadan in comparison with 74% (N = 1,523) of the control group. Those with DKD experienced higher rates of hypoglycemia (65.1%) and hyperglycemia (69.6%) than the control group (56.5 and 42.5%, respectively). They also had more frequent emergency visits and hospitalizations. Additionally, among individuals with T1D and DKD, nonfasters exhibited significant differences in biochemical markers and demographics compared with those who fasted.
Conclusion
Individuals with T1D and DKD are generally older, have multiple diabetes-related complications, and are less likely to fast during Ramadan. For those who do fast, the risks are significant, including higher rates of hypoglycemia and hospital admissions compared with the control group. Ensuring safe fasting in this population requires interdisciplinary collaboration, patient education, and expert medical guidance.
Keywords
Ramadan fasting - type 1 diabetes mellitus - diabetic kidney disease - hypoglycemia - hyperglycemia - diabetes education - self-monitoring of blood glucose - risk stratificationAuthors' Contributions
All authors contributed toward conception, data collection, writing, and final approval of the manuscript.
Compliance with Ethical Principles
Ethical approval was not required for this subanalysis. Original studies were approved by the ethical committees of the participating sites.
Publikationsverlauf
Artikel online veröffentlicht:
26. September 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392 (10159): 1789-1858 Erratum in: The Lancet. 2019;393(10190):e44
- 2 Rossing P, Hougaard P, Borch-Johnsen K, Parving HH. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ 1996; 313 (7060): 779-784
- 3 Dena M, Svensson AM, Olofsson KE. et al. Renal complications and duration of diabetes: an international comparison in persons with type 1 diabetes. Diabetes Ther 2021; 12 (12) 3093-3105
- 4 Ricciardi CA, Gnudi L. Kidney disease in diabetes: from mechanisms to clinical presentation and treatment strategies. Metabolism 2021; 124: 154890
- 5 Wu T, Ding L, Andoh V, Zhang J, Chen L. The mechanism of hyperglycemia-induced renal cell injury in diabetic nephropathy: an update. Life (Basel) 2023; 13 (02) 539
- 6 Salem MM. Pathophysiology of hypertension in renal failure. Semin Nephrol 2002; 22 (01) 17-26
- 7 Ahmad S, Chowdhury TA. Fasting during Ramadan in people with chronic kidney disease: a review of the literature. Ther Adv Endocrinol Metab 2019;10:2042018819889019
- 8 AlSahow A. The impact of hot ambient temperature and prolonged fasting duration during Ramadan on patients with chronic kidney disease: a literature review. Int J Nephrol 2023; 2023: 2636507
- 9 NasrAllah MM, Osman NA. Fasting during the month of Ramadan among patients with chronic kidney disease: renal and cardiovascular outcomes. Clin Kidney J 2014; 7 (04) 348-353
- 10 Bentaleb M, Sersar I, Bencharif M. et al. Type 1 diabetes mellitus and Ramadan fasting: a case of adolescents and adults from Algeria. Nutr Clin Metab 2023; 37 (04) 214-220
- 11 Hassanein M, Yousuf S, Ahmedani MY. et al. Ramadan fasting in people with diabetes and chronic kidney disease (CKD) during the COVID-19 pandemic: the DaR global survey. Diabetes Metab Syndr 2023; 17 (07) 102799
- 12 Chowdhury A, Khan H, Lasker SS, Chowdhury TA. Fasting outcomes in people with diabetes and chronic kidney disease in East London during Ramadan 2018: the East London diabetes in Ramadan survey. Diabetes Res Clin Pract 2019; 152: 166-170
- 13 Hassanein M, Afandi B, Yakoob Ahmedani M. et al. Diabetes and Ramadan: practical guidelines 2021. Diabetes Res Clin Pract 2022; 185: 109185
- 14 Hassanein M, Binte Zainudin S, Shaikh S. et al. An update on the current characteristics and status of care for Muslims with type 2 diabetes fasting during Ramadan: the DAR global survey 2022. Curr Med Res Opin 2024; 40 (09) 1515-1523
- 15 Radcliffe NJ, Seah JM, Clarke M, MacIsaac RJ, Jerums G, Ekinci EI. Clinical predictive factors in diabetic kidney disease progression. J Diabetes Investig 2017; 8 (01) 6-18
- 16 Bash LD, Selvin E, Steffes M, Coresh J, Astor BC. Poor glycemic control in diabetes and the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med 2008; 168 (22) 2440-2447
- 17 Roy S, Schweiker-Kahn O, Jafry B. et al. Risk factors and comorbidities associated with diabetic kidney disease. J Prim Care Community Health 2021 12. 21501327211048556
- 18 Jia G, Bai H, Mather B, Hill MA, Jia G, Sowers JR. Diabetic vasculopathy: molecular mechanisms and clinical insights. Int J Mol Sci 2024; 25 (02) 804
- 19 Moen MF, Zhan M, Hsu VD. et al. Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol 2009; 4 (06) 1121-1127
- 20 Akram K, Pedersen-Bjergaard U, Borch-Johnsen K, Thorsteinsson B. Frequency and risk factors of severe hypoglycemia in insulin-treated type 2 diabetes: a literature survey. J Diabetes Complications 2006; 20 (06) 402-408
- 21 Ahmed SH, Chowdhury TA, Hussain S. et al. Ramadan and diabetes: a narrative review and practice update. Diabetes Ther 2020; 11 (11) 2477-2520
- 22 El Toony LF, Hamad DA, Omar OM. Outcome of focused pre-Ramadan education on metabolic and glycaemic parameters in patients with type 2 diabetes mellitus. Diabetes Metab Syndr 2018; 12 (05) 761-767